Company Badge
USPTO Data Jan 1 1976 - Sep 29 2026
17 Patents
#79 in Boulder, CO
#386 in Colorado
#18,865 in US
#35,857 in the World
N30 Pharmaceuticals, Inc.
Forward Citations = 89
6 inventors:
Boulder, CO, United States of America
N30 Pharmaceuticals, Inc.
% Expired Patents = 88.2
EPO Patents = 4
Forward Citations = 89
Loading Chart...
Loading Chart...
6 inventors (with patents filed for the assignee):
Xicheng David Sun (17 out of 49 patents)
Jian Qiu (15 out of 38 patents)
Jan William Wasley (9 out of 30 patents)
4. Sarah A Strong (7 out of 24 patents)
5. Gary Joseph Rosenthal (7 out of 18 patents)
6. Adam Stout (2 out of 10 patents)
17 patents:
1. 8957105 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2015-02-17),
3. 8921562 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2014-12-30),
4. 8906933 - Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonists (2014-12-09),
6. 8846736 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2014-09-30),
10. 8691816 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2014-04-08),
11. 8686015 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2014-04-01),
N30 Pharmaceuticals, Inc. is a biopharmaceutical company committed to discovering and developing innovative treatments for respiratory diseases. Our focus lies in creating therapies that target key inflammatory pathways to significantly improve patients' lives. With a dedicated team and state-of-the-art research facilities, we aim to revolutionize the field of respiratory medicine.
Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Please report any incorrect information to [email protected]
4 patents (EPO):
Please report any incorrect information to [email protected]